Skip to main content
. 2017 May 16;12(5):e0177163. doi: 10.1371/journal.pone.0177163

Table 1. Descriptive, clinical data, choroidal thicknesses and volume for eyes of patients with Parkinson’s disease and from healthy controls (validating population).

PD PATIENTS CONTROLS P*
Number of eyes 40 40 -
Age (years) 69.8 ± 6.5 68.6 ± 7.2 0.137
Sex (men/women) 26/14 26/14 0.901
Spherical Equivalent (D) 0.14 ± 1.76 0.13 ± 1.88 0.388
Number of myopic subjects (%) ** 18 (45%) 17 4(42.5%) 0.404
Number of hyperopic subjects (%)** 6 (15%) 6 (15%) 0.945
BCVA (LogMAR) 0.11 ± 0.17 0.03 ± 0.16 0.005
IOP (mm Hg) 16.5 ± 2.0 16.2 ± 2.8 0.439
Disc area (mm2) 1.92 ± 0.37 1.89 ± 0.37 0.309
Unified Parkinson Disease Rating Scale 25.1 ± 5.4 - -
Hoehn and Yahr Scale 2.7 ± 0.8 -
Disease duration (years) 6.7 ± 2.3 - -
Choroidal thickness (μm)
    Zone 2 126.89 ± 11.23 96.53 ± 9.55 <0.0001
    Zone 3 152.75 ± 16.00 121.39 ± 12.10 <0.0001
    Zone 4 190.21 ± 12.16 156.69 ± 12.44 <0.0001
    Zone 5 213.21 ± 11.83 186.64 ± 9.47 <0.0001
    Total 163.01 ± 29.90 131.51 ± 30.22 <0.0001
Number of peripapillary cubes
    70–104 μm thick 0 116 <0.0001
    105–139 μm thick 165 258 <0.0001
    140–174 μm thick 202 175 <0.0010
    ≥175 μm thick 221 39 <0.0001

Comparison of the choroidal thicknesses in the four established zones in the control group and Parkinson’s disease patients, and comparison between groups. Comparison of the number of peripapillary cubes with a thickness from 70 to 104 μm (zone 2), from 105 to 139 μm (zone 3); from 140 to 174 μm (zone 4), and ≥ 175 μm (zone 5). Zone 1 corresponds to the optic nerve head and was not included in the analysis.

* p: level of statistical significance in comparison between the two groups using Student’s t-test (except for sex, chi-square test). Data are mean ± standard deviation. Bold text indicates statistically significant results (p<0.05).

** Subjects were considered myopic when spherical equivalent was < -1D. Subjects were considered hyperopic when spherical equivalent was >1D. Abbreviations: PD, Parkinson´s disease; D, diopters; BCVA, best-corrected visual acuity; IOP, intraocular pressure.